Nuklearmedizin 2021; 60(05): 326-343
DOI: 10.1055/a-1525-7029
DOI: 10.1055/a-1525-7029
Review
Value of PET imaging for radiation therapy[*]
Wertigkeit der PET-Bildgebung für die RadioonkologieAuthors
-
Constantin Lapa
1 Nuclear Medicine, Medical Faculty, University of Augsburg, Augsburg, Germany -
Ursula Nestle
2 Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany3 German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany4 Department of Radiation Oncology, Kliniken Maria Hilf, Mönchengladbach, Germany -
Nathalie L. Albert
5 Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany -
Christian Baues
6 Department of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany -
Ambros Beer
7 Department of Nuclear Medicine, Ulm University Hospital, Ulm, Germany -
Andreas Buck
8 Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany -
Volker Budach
9 Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Campus Virchow-Klinikum, Berlin, Germany -
Rebecca Bütof
10 Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany11 OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany -
Stephanie E. Combs
12 German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany13 Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany14 Department of Radiation Sciences (DRS), Institute of Radiation Medicine (IRM), Neuherberg, Germany -
Thorsten Derlin
15 Department of Nuclear Medicine, Hannover Medical School, Germany -
Matthias Eiber
16 Department of Nuclear Medicine, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany -
Wolfgang P. Fendler
17 Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany -
Christian Furth
18 Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany -
Cihan Gani
19 German Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany20 Department of Radiation Oncology, University of Tübingen, Tübingen, Germany -
Eleni Gkika
2 Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany -
Anca L. Grosu
2 Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany3 German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany -
Christoph Henkenberens
21 Department of Radiotherapy and Special Oncology, Medical School Hannover, Germany -
Harun Ilhan
5 Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany -
Steffen Löck
10 Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany11 OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany -
Simone Marnitz-Schulze
6 Department of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany -
Matthias Miederer
22 Department of Nuclear Medicine, University Hospital Mainz, Mainz, Germany -
Michael Mix
23 Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany -
Nils H. Nicolay
2 Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany3 German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany -
Maximilian Niyazi
5 Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany12 German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany -
Christoph Pöttgen
24 Department of Radiation Oncology, West German Cancer Centre, University of Duisburg-Essen, Essen, Germany -
Claus M. Rödel
25 German Cancer Consortium (DKTK), Partner Site Frankfurt, and German Cancer Research Center (DKFZ), Heidelberg, Germany26 Department of Radiotherapy and Oncology, Goethe University Frankfurt, Frankfurt, Germany -
Imke Schatka
18 Department of Nuclear Medicine, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany -
Sarah M. Schwarzenboeck
27 Department of Nuclear Medicine, Rostock University Medical Centre, Rostock, Germany -
Andrei S. Todica
5 Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany -
Wolfgang Weber
16 Department of Nuclear Medicine, Technical University of Munich (TUM), Klinikum rechts der Isar, Munich, Germany -
Simone Wegen
6 Department of Radiation Oncology, Cyberknife and Radiotherapy, Medical Faculty, University Hospital Cologne, Cologne, Germany -
Thomas Wiegel
28 Department of Radiation Oncology, Ulm University Hospital, Ulm, Germany -
Constantinos Zamboglou
2 Department of Radiation Oncology, Faculty of Medicine, University Medical Center Freiburg, Freiburg, Germany3 German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany -
Daniel Zips
19 German Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany20 Department of Radiation Oncology, University of Tübingen, Tübingen, Germany -
Klaus Zöphel
11 OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany29 National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany30 German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany31 Department of Nuclear Medicine, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany32 Department of Nuclear Medicine, Klinikum Chemnitz gGmbH, Chemnitz, Germany -
Sebastian Zschaeck
33 Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Charité-Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany -
Daniela Thorwarth
19 German Cancer Consortium (DKTK), Partner Site Tübingen, and German Cancer Research Center (DKFZ), Heidelberg, Germany34 Section for Biomedical Physics, Department of Radiation Oncology, University of Tübingen, Tübingen, Germany -
10 Department of Radiotherapy and Radiation Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany11 OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany29 National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Helmholtz Association/Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Dresden, Germany30 German Cancer Consortium (DKTK), Partner Site Dresden, and German Cancer Research Center (DKFZ), Heidelberg, Germany35 Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiooncology – OncoRay, Dresden, Germany

